Worldwide Shipping Sars-cov-2 Spike S1 Protein (cov-vm2s1) With Free Shipping [qGlpECy3]

SARS-CoV-2 Spike S1 Protein (COV-VM2S1)

Introducing our cutting-edge SARS-CoV-2 Spike S1 Protein (COV-VM2S1), a revolutionary product designed for researchers and scientists in the field of virology and immunology. This high-purity protein is derived from the spike protein of the SARS-CoV-2 virus, offering a reliable and efficient tool for various research applications. With its exceptional purity and stability, our Spike S1 Protein is ideal for use in antibody production, vaccine development, and diagnostic assays. Key features include:

• High purity and stability
• Convenient for use in various research applications
• Supports antibody production and vaccine development

Product Properties and Specifications

Our SARS-CoV-2 Spike S1 Protein (COV-VM2S1) is produced through a state-of-the-art expression system, ensuring optimal protein yield and functionality. The protein is purified to a high level of purity, exceeding 95%, and is supplied in a lyophilized form for easy storage and handling. The protein is also characterized by its stability, maintaining its biological activity even after long-term storage. Key specifications include:

• Purity: >95%
• Expression system: E. coli
• Storage: -20°C

These properties make our product a valuable asset for researchers seeking accurate and reliable results in their studies.

Practical Uses and Benefits

The SARS-CoV-2 Spike S1 Protein (COV-VM2S1) is a versatile tool that can be utilized in a wide range of research applications. Its high purity and stability make it an excellent choice for producing antibodies against the SARS-CoV-2 virus, which is crucial for vaccine development and diagnostic testing. Additionally, this protein can be used in cell-based assays to study the interaction between the virus and host cells, providing valuable insights into the pathogenesis of COVID-19. Target audience includes:

• Research institutions and universities
• Biotechnology companies
• Government health organizations

By using our SARS-CoV-2 Spike S1 Protein, researchers can accelerate their studies and contribute to the global effort in combating the COVID-19 pandemic.